doi:10.3969/j.issn.1673-8640.2020.05.014

Abstract

CLC Number:

R446.1

Figures/Tables 4

References 12

[1]	范铮,沈丽萍,姚建华. 小儿疱疹性咽炎的病原学研究[J]. 浙江临床医学,2018,10(5):600-601.
[2]	EL HOUMAMI N,MINODIER P,DUBOURG G,et al.An outbreak of Kingella kingae infections associated with hand,foot and mouth disease/herpangina virus outbreak in Marseille,France,2013[J]. Pediatr Infect Dis J,2015,34(3):246-250.
[3]	CHEN Z,LI R,XIE Z,et al.IL-6,IL-10 and IL-13 are associated with pathogenesis in children with enterovirus 71 infection[J]. Int J Clin Exp Med,2014,7(9):2718-2723.
[4]	KURTIPEK E,BEKCI T T,KESLI R,et al.The role of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in exacerbation of chronic obstructive pulmonary disease[J]. J Pak Med Assoc,2015,65(12):1283-1287.
[5]	KAYRAK M,ERDOAN H I,SOLAK Y,et al.Prognostic value of neutrophil to lymphocyte ratio in patients with acute pulmonary embolism:a retrospective study[J]. Heart Lung Circ,2014,23(1):56-62.
[6]	夏蝉,余坚,金龙腾,等. 疱疹性口炎与疱疹性咽峡炎的病原学检测[J]. 中华全科医学,2016,14(10):1719-1722.
[7]	何亚萍,杜潘艳,郑建霞. 疱疹性咽峡炎患儿体内3种相关病毒检测及临床意义[J]. 中国热带医学,2016,16(1):90-92.
[8]	LIU H,ZHANG H,WAN G,et al.Neutrophil-lymphocyte ratio:a novel predictor for short-term prognosis in acute-on-chronic hepatitis B liver failure[J]. J Viral Hepat,2014,21(7):499-507.
[9]	ZAHOREC R.Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill[J]. Bratisl Lek Listy,2001,102(1):5-14.
[10]	PIROZZLO G,GISBERTZ S S,CASTORO C,et al.Neutrophil-to-lymphocyte ratio as prognostic marker in esophageal cancer:a systematic review and meta-analysis[J]. J Thorac Dis,2019 ,11(7):3136-3145.
[11]	WANG Z,GONG Q,GUO C,et al.Neutrophil-to-lymphocyte ratio predicts hematoma growth in intracerebral hemorrhage[J]. J Int Med Res,2019,47(7):2970-2975.
[12]	FARZANEH F,FAGHIH N,HOSSEINI M S,et al.Evaluation of neutrophil-lymphocyte ratio as a prognostic factor in cervical intraepithelial neoplasia recurrence[J]. Asian Pac J Cancer Prev,2019,20(8):2365-2372.

组别	例数	CRP/（mg/L）	WBC计数/（×10⁹/L）	NEUT%/%	LYMPH%/%	NLR
实验组	67
治疗前		27.87（30.40）	14.60±5.61	63.9±12.9	26.1±11.6	3.22±2.07
治疗后		3.63（4.97）	6.86±1.76	28.0±11.6	61.0±11.2	0.42（0.25）
对照组	44	0.86（1.74）	7.20±1.46	32.2±9.0	58.5±9.4	0.60±0.32

组别	例数	CRP/（mg/L）	WBC计数/（×10⁹/L）	NEUT%/%	LYMPH%/%	NLR
实验组	67
治疗前		27.87（30.40）	14.60±5.61	63.9±12.9	26.1±11.6	3.22±2.07
治疗后		3.63（4.97）	6.86±1.76	28.0±11.6	61.0±11.2	0.42（0.25）
对照组	44	0.86（1.74）	7.20±1.46	32.2±9.0	58.5±9.4	0.60±0.32

项目	阳性例数	阳性率/%
RSV	0	0.00
ADV	0	0.00
INFA	2	2.99
INFB	10	14.93
PIV	0	0.00
CP	1	1.49
MP	27	40.30
LP	0	0.00

项目	阳性例数	阳性率/%
RSV	0	0.00
ADV	0	0.00
INFA	2	2.99
INFB	10	14.93
PIV	0	0.00
CP	1	1.49
MP	27	40.30
LP	0	0.00

组别	治疗前
组别	CRP/（mg/L）	WBC计数/（×10⁹/L）	NEUT%/%	LYMPH%/%	NLR
MP阳性组	27.40（26.56）	16.19±5.91	70.1±10.9^*	20.4±8.8^*	4.44±2.67^*
MP阴性组	27.04（39.80）	13.62±5.20	59.8±12.9	29.7±12.1	2.55±1.53
组别	治疗后
组别	CRP/（mg/L）	WBC计数/（×10⁹/L）	NEUT%/%	LYMPH%/%	NLR
MP阳性组	3.49（3.27）	6.54±1.59	28.0±10.7	60.6±9.7	0.42（0.20）
MP阴性组	3.71（5.21）	7.1±1.81	28.1±12.4	61.0±12.2	0.42（0.29）

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 4

References 12

Related Articles 15

Recommended Articles

Metrics

[1]	GAO Zikang, CHEN Jing. Construction of a nomogram prediction model for the prognosis of patients with depressive disorder based on the characteristics of peripheral blood lymphocyte subsets [J]. Laboratory Medicine, 2025, 40(12): 1146-1152.
[2]	WANG Tian, ZHANG Yun, BAI Yi, ZHAI Weibin, ZHAO Hai. Roles of PIV，SII and NPAR in the diagnosis of spontaneous bacterial peritonitis in patients with liver cirrhosis and ascites [J]. Laboratory Medicine, 2025, 40(12): 1153-1158.
[3]	HUANG Ting, XU Yan, SHI Qingxing, PENG Ying. Roles of miR-944 and MARCH7 mRNA in prognosis assessment of non-small cell lung cancer patients [J]. Laboratory Medicine, 2025, 40(12): 1159-1164.
[4]	LI Minghong, MIN Cuili, GUO Qingbo, MA Lujuan. Predictive roles of serum 25（OH）D and SAA for the response to immunosuppressive therapy in autoimmune hepatitis [J]. Laboratory Medicine, 2025, 40(12): 1165-1170.
[5]	ZHEN Di, JIA Bin, MENG Xianyi. Roles of serum sPD-1 and sTWEAK levels in patients with ulcerative colitis in disease monitoring and prognosis assessment [J]. Laboratory Medicine, 2025, 40(12): 1171-1176.
[6]	ZHAO Yilin, XU Yan, YIN Hui. Roles of serum miR-145-5p，miR-200C-3p and miR-1290 in prognosis assessment of patients with papillary thyroid carcinoma [J]. Laboratory Medicine, 2025, 40(12): 1177-1182.
[7]	LI Song, XIANG Xu. Risk factors for poor prognosis in elderly patients with severe fever and thrombocytopenia syndrome and their clinical significance [J]. Laboratory Medicine, 2025, 40(12): 1183-1189.
[8]	CHANG Nan, WEI Yali, LU Qifeng, LI Tian, HOU Tingting, LI Yuan, ZHU Mengyu, SHEN Yajuan. A machine learning early warning model for acute promyelocytic leukemia based on blood cell analyzer parameters [J]. Laboratory Medicine, 2025, 40(12): 1190-1196.
[9]	. [J]. Laboratory Medicine, 2025, 40(12): 1197-1202.
[10]	. [J]. Laboratory Medicine, 2025, 40(12): 1216-1221.
[11]	. [J]. Laboratory Medicine, 2025, 40(12): 1222-1226.
[12]	BAO Wen. Application and prospect of microsatellite instability determination in tumor diagnosis and treatment [J]. Laboratory Medicine, 2025, 40(12): 1227-1231.
[13]	XIONG Ying, GUO Wei. From generic to personalized：the evolution and frontiers of indirect methods for establishing reference interval [J]. Laboratory Medicine, 2025, 40(11): 1035-1041.
[14]	CHEN Yanqin, FAN Lina, YANG Dagan. Six indirect method algorithms for establishing the reference range of serum cystatin C for adults in Hangzhou and consistency analysis [J]. Laboratory Medicine, 2025, 40(11): 1047-1052.
[15]	LIU Chunyan, NIU Shumin, DENG Zhaohui, LIANG Mengjie, ZHANG Xin. Establishing the reference ranges for AFP，CEA，CA72-4 and CA19-9 in Urumqi region by indirect method [J]. Laboratory Medicine, 2025, 40(11): 1053-1058.